BC
VCYT icon

Bayforest Capital’s Veracyte VCYT Stock Holding History

Bayforest Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.5K Sell
1,196
-1,335
-53% -$49.4K 0.04% 627
2025
Q4 		$107K Sell
2,531
-12,494
-83% -$504K 0.08% 451
2025
Q3 		$516K Buy
+15,025
New +$431K 0.25% 130

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bayforest Capital's VCYT Position: Q1 2026 in Review

Bayforest Capital reduced its Veracyte (VCYT) stake by 53% in Q1 2026, selling an estimated $49.4K and leaving 1,196 shares worth $38.5K. The position accounts for 0.04% of the portfolio, ranked #627.

Bayforest Capital first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $516K in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Bayforest Capital held 1,196 shares of Veracyte worth $38.5K as of Q1 2026.
  • Bayforest Capital sold 1,335 Veracyte shares in Q1 2026, an estimated $49.4K.
  • Veracyte made up 0.04% of Bayforest Capital's portfolio in Q1 2026, its #627 holding.
  • Bayforest Capital first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • Bayforest Capital's Veracyte position peaked at $516K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.